Business● LowAug 28 · Aug 28, 2026, 12:59 PM
Alnylam drops as AstraZeneca posts full trial results for failed heart drug
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Alnylam's stock price dropped after AstraZeneca released full trial results for a heart drug that reportedly failed. This financial movement reflects the impact of pharmaceutical research outcomes on company valuations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business18m agoBitcoin today: BTC quote and price this Saturday, November 7, 2026ClarínBusiness32m agoCard dollar today: how much it quotes this Saturday, November 07ClarínBusiness32m agoCCL Dollar today: how much it quotes this Saturday, November 07ClarínBusiness35m agoMEP Dollar today: how much it quotes this Saturday, November 07Clarín